Guided Therapeutics (GTHP) Current Leases (2019 - 2025)
Guided Therapeutics' (GTHP) quarterly Current Leases came in at $45000.0 in Q4 2025, down 57.55% year-on-year from $106000.0 in Q4 2024, and down 40.79% quarter-over-quarter from $76000.0 in Q3 2025.
Guided Therapeutics (GTHP) Current Leases (2019 - 2025) Analysis & Trends
Guided Therapeutics has disclosed Current Leases across 7 years of filings, most recently posting $45000.0 for Q4 2025.
- Current Leases for Q4 2025 came in at $45000.0, down 57.55% year-over-year; the trailing twelve-month figure through Dec 2025 was $45000.0 (down 57.55% YoY), and the FY2025 annual result was $45000.0, down 57.55% from the prior year.
- Current Leases came in at $45000.0 for Q4 2025 at Guided Therapeutics, down from $76000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $110000.0 in Q1 2025 to a low of $42000.0 in Q1 2021.
- The 5-year median for Current Leases is $80500.0 (2022), against an average of $80800.0.
- Across the five-year window, Current Leases tumbled 57.58% in 2021 and surged 66.67% in 2022, its largest moves.
- Guided Therapeutics' Current Leases stood at $67000.0 in 2021, then increased by 17.91% to $79000.0 in 2022, then grew by 15.19% to $91000.0 in 2023, then advanced by 16.48% to $106000.0 in 2024, then plunged by 57.55% to $45000.0 in 2025.
- The last three Current Leases figures came in at $45000.0 (Q4 2025), $76000.0 (Q3 2025), and $104000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 24.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 20.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 35.80 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 45,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 45,000.00 |
| Sep 30, 2025 | 76,000.00 |
| Jun 30, 2025 | 104,000.00 |
| Mar 31, 2025 | 110,000.00 |
| Dec 31, 2024 | 106,000.00 |
| Sep 30, 2024 | 102,000.00 |
| Jun 30, 2024 | 99,000.00 |
| Mar 31, 2024 | 95,000.00 |
| Dec 31, 2023 | 91,000.00 |
| Sep 30, 2023 | 88,000.00 |
| Jun 30, 2023 | 85,000.00 |
| Mar 31, 2023 | 82,000.00 |
| Dec 31, 2022 | 79,000.00 |
| Sep 30, 2022 | 76,000.00 |
| Jun 30, 2022 | 73,000.00 |
| Mar 31, 2022 | 70,000.00 |
| Dec 31, 2021 | 67,000.00 |
| Sep 30, 2021 | 64,000.00 |
| Jun 30, 2021 | 62,000.00 |
| Mar 31, 2021 | 42,000.00 |